Cargando…

Pan-cancer Integrative Molecular Portrait Towards a New Paradigm in Precision Medicine

This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques,...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Le Tourneau, Christophe (Editor ), Kamal, Maud (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edición:1st ed. 2015.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-22189-2
003 DE-He213
005 20220112224647.0
007 cr nn 008mamaa
008 150827s2015 sz | s |||| 0|eng d
020 |a 9783319221892  |9 978-3-319-22189-2 
024 7 |a 10.1007/978-3-319-22189-2  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Pan-cancer Integrative Molecular Portrait Towards a New Paradigm in Precision Medicine  |h [electronic resource] /  |c edited by Christophe Le Tourneau, Maud Kamal. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a X, 144 p. 100 illus., 50 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction: Rationale for Precision Medicine Clinical Trials.-  The Key Role of Pathology in the Context of Precision Medicine Trials -- Basis for Molecular Genetics in Cancer -- Microarrays Based Molecular Profiling to Identify Genomic Alterations -- High Throughput Technologies: DNA and RNA Sequencing Strategies and Potential -- Bioinformatics for Precision Medicine in Oncology -- Assessment of Biomarkers' Predictive Value of Efficacy -- Designs for Evaluating Precision Medicine Trials -- Conclusions and Perspectives: Challenges for the Clinical Implementation of Precision Medicine Trials. 
520 |a This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the world's foremost cancer research institutions. 
650 0 |a Oncology. 
650 0 |a Pathology. 
650 0 |a Cancer. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 1 4 |a Oncology. 
650 2 4 |a Pathology. 
650 2 4 |a Cancer Biology. 
650 2 4 |a Biomedical Research. 
700 1 |a Le Tourneau, Christophe.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Kamal, Maud.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319221885 
776 0 8 |i Printed edition:  |z 9783319221908 
776 0 8 |i Printed edition:  |z 9783319371764 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-22189-2  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)